About FDA
SMG 1117.442
FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS
FOOD AND DRUG ADMINISTRATION
OFFICE OF THE COMMISSIONER
OFFICE OF OPERATIONS
OFFICE OF FINANCIAL MANAGEMENT
OFFICE OF FINANCIAL SERVICES
DIVISION OF PAYMENT SERVICES
Effective Date: 01/13/2009
1. DIVISION OF PAYMENT SERVICES (DAMGDB).
A. Performs billing and collecting services for headquarters accounts. Maintains internal control over processing of transactions to accounts, including application of batch controls to ensure accurate coding and making of necessary accounting transaction adjustments and corrections.
B. Maintains liaison with the Department of Central Payroll on headquarters payroll operations. Reconciles payroll data with accounts. Maintains tax withholding files. Issues withholding statements.
C. Processes employee time records; resolves payroll errors and assists employees with pay problems; issues new procedures as needed.
D. Participates in reengineering the payroll process to streamline correction of errors and reduce first time errors; and participates in timekeeper training.
E. Processes all purchase orders, receiving reports, and invoices for commercial payments made by the Food and Drug Administration (FDA) headquarters, assuring compliance with accounts and the Prompt Pay Act.
F. Coordinates with vendor and center personnel in researching payment information.
G. Responds to all vendor inquiries as well as inquiries from center personnel.
H. Prepares various reconciliations to ensure that schedules are properly accounted for and entered into the accounting system.
I. Reviews and distributes monthly accounting reports and processes corrections, as necessary.
J. Liaison with the Department of Treasury to initiate checks traces.
2. AUTHORITY AND EFFECTIVE DATE.
The functional statements for this Office were approved by the Commissioner, Food and Drug, effective January 13, 2009.
| STATUS (I, R, C) | DATE APPROVED | LOCATION OF CHANGE HISTORY | CONTACT | APPROVING OFFICIAL |
|---|---|---|---|---|
| Initial | 01/13/2009 | N/a | OC/OO/OM/OMP | Commissioner of the Food and Drug Administration |

